Work

A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine

Year: 1998

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PEDIATRICS

DOI: 10.1542/peds.101.1.1

Authors: Klemens Stehr, James D. Cherry, Ulrich Heininger, Sabina Schmitt-Grohé, Michael Überall, Suzanne Laussucq, Thomas Eckhardt, Martin Meyer, Rita Engelhardt, Peter Christenson, the Pertussis Vaccine Study Group

Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, University of California, Los Angeles

Language: English

Topic: Bacterial Infections and Vaccines

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2052180986

FWCI: 20.47

Cites: 48

Cited by: 511

Related to: 10